![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Comorbid Conditions Associated With Decision-Making Regarding Treating or Not Treating Chronic Hepatitis C In A Large U.S. Health Maintenance Organization
|
|
|
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
Lisa M. Nyberg1, Kevin M. Chiang2, Zhaoliang Li2, Anders H. Nyberg1, Zobair M. Younossi3, T. Craig Cheetham4
1. Hepatology Research, Kaiser Permanente, San Diego, CA, USA
2. Pharmacy Analytical Services, Kaiser Permanente, Downey, CA, USA
3. Center for Liver Diseases, Dept. of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA
4. Kaiser Permanente, Department of Research and Evaluation, Pasadena, CA, USA
![EASL1.gif](../images/041814/041814-1/EASL1.gif)
![EASL2.gif](../images/041814/041814-1/EASL2.gif)
![EASL3.gif](../images/041814/041814-1/EASL3.gif)
![EASL4.gif](../images/041814/041814-1/EASL4.gif)
![EASL5.gif](../images/041814/041814-1/EASL5.gif)
![EASL6.gif](../images/041814/041814-1/EASL6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|